Abstract
Increased sensitivity and chemical shift dispersion at ultra-high magnetic fields (UHF) enable precise quantification of an extended range of brain metabolites from 1H MR spectra. However, all previous neurochemical profiling studies using single-voxel MRS at 7 T were limited to data acquired from the occipital lobe with half-volume coils. Challenges of 1H MRS of the human brain at 7 T include short T2 and complex B1 distribution that imposes limitations in maximum achievable B1 strength. In this study, the feasibility of acquiring and quantifying short-echo (TE = 8 ms), single voxel 1H MR spectra from multiple brain regions was demonstrated by utilizing a 16-channel transceiver array coil with 16 independent transmit channels allowing local transmit B1 (B1+) shimming. Spectra were acquired from volumes-of-interest of 1 – 8 mL in brain regions that are of interest for various neurological disorders: frontal white matter, posterior cingulate, putamen, substantia nigra, pons and cerebellar vermis. Local B1+ shimming substantially increased transmit efficiency, especially in the peripheral and ventral brain regions. By optimizing a STEAM sequence for utilization with a 16-channel coil, artifact-free spectra were acquired with a small chemical shift displacement error (< 5% /ppm/direction) from all regions. The high SNR enabled the quantification of neurochemical profiles consisting of at least 9 metabolites including GABA, glutamate and glutathione in all brain regions. Significant differences in neurochemical profiles were observed between brain regions. For example, GABA levels were highest in the substantia nigra, total creatine highest in the cerebellar vermis and total choline highest in the pons, consistent with known biochemistry of these regions. These findings demonstrate that single voxel 1H MRS at UHF can reliably detect region-specific neurochemical patterns in the human brain and has the potential to objectively detect alterations in neurochemical profiles associated with neurological diseases.
Keywords: MRS, B1+ shimming, short echo time, transceiver array coil, neurochemical profile, single voxel
Introduction
The advantages of ultra-high field (UHF) MR have been demonstrated in a variety of MR acquisition modalities (1). MRS can particularly benefit from substantial gains in signal-to-noise ratio (SNR) and spectral resolution at UHF, enabling the quantification of numerous metabolites from small volumes-of-interest (VOIs). For example, concentrations of up to 18 neurochemicals can be quantified from selected regions in the human brain at 7 T (2–4). SNR is approximately two-fold and resolution 14% higher at 7 T relative to 4 T in the occipital cortex (2). As a result, metabolites are quantified with higher precision (lower Cramér-Rao Lower Bounds, CRLB) at 7 T than at 4 T, which is particularly critical for weakly represented neurochemicals (2). Despite this potential, short-echo 1H MRS studies that reported neurochemical profiles of the human brain at 7 T were primarily focused on the occipital lobe (2–8) due to multiple challenges faced when using a standard volume head coil at UHF. First, the power to generate B1 increases approximately linearly with magnetic field (9). As a result, the maximum magnitude of B1+ achievable with conventional volume head coils and available RF power are insufficient to generate conventional 90° or 180° RF pulses with bandwidths large enough to minimize chemical shift displacement errors in spectroscopy. This problem is exacerbated in large regions of the brain due to the destructive interferences that result in submaximal B1+ when volume coils circumscribing the whole head are used (10). Second, T2 relaxation times of metabolites in the human brain are relatively short at this field (11,12) and the SNR advantages quickly disappear with increasing echo times. Therefore, short echo times are critical for quantifying neurochemical profiles and are particularly important for reliable quantification of metabolites with coupled spin systems, such as glutamine (Gln), glutamate (Glu) and glutathione (GSH).
New excitation and saturation pulses can be designed to partially overcome problems resulting from limitations in available B1+ magnitude. For example, MR spectroscopic imaging (MRSI) data were recently obtained using the FIDLOVS technique (13), based on 2D pre-localization by outer volume suppression (OVS) and slice-selective excitation with a newly designed broadband frequency-modulated RF pulse. Alternatively, the RF power required to achieve a given magnitude of B1+ in a local area can be reduced by utilizing an array of transmit coil elements and optimizing the phase and/or magnitude of RF delivered to each transmit element (B1+ shimming) (10,12,14,15). Recently, a similar approach has been employed to acquire MRSI data from brain slices at 7 T, demonstrating the feasibility of detecting myo-inositol (myo-Ins), Glu and Gln, in addition to N-acetylaspartate (NAA), creatine and choline (16,17). In these MRSI studies (13, 16, 17) relative metabolite concentrations were reported because acquisition of water reference data needed for absolute quantification would double the scan time. Another challenge with obtaining MRSI data for metabolite quantification is that efforts for improving the homogeneity of B1+ over a large volume generally result in decreased RF efficiency (18). On the other hand, in the single voxel spectroscopy approach, high RF efficiency to maximize B1+ over small VOIs can be readily achieved using local B1+ shimming, as was demonstrated in the human head at 9.4 T (12).
Another advantage of the single voxel approach is the ease with which the static magnetic field homogeneity can be adjusted. B0 shimming is a key factor for successful MRS at 7 T, because it determines the achieved spectral resolution, which consequently affects the reliability of metabolite quantification. It has been demonstrated that a strong second-order shim system is sufficient to compensate B0 inhomogeneities in reasonably small volumes (2,7). On the other hand, to achieve acceptable linewidths over the slice, the MRSI studies mentioned above (13,16,17) utilized third order B0 shimming, a feature which is absent from most 7 T scanners, including our equipment. Therefore, in the absence of third or even higher order shims to attain sufficient B0 homogeneity over large volumes in the brain, single voxel spectroscopy provides an alternative to MRSI for acquisition of very high quality spectra.
Finally, single voxel MRS might be preferable over the MRSI approach for clinical applications where the affected brain region is known and where motion artifacts are common (19–21). The phase and frequency instabilities induced by patient motion can be eliminated from single voxel MRS data by post-processing, provided that single scan spectra are clean, and uncorrectable scans can be removed from the final FID summation (22). In addition, the single voxel approach allows one to abort the acquisition at any time and use the limited data set for metabolite quantification.
In this study, we tested the feasibility of acquiring and quantifying short-echo (TE = 8 ms), single voxel 1H MR spectra from multiple brain regions utilizing the STEAM sequence (7,22), a 16-channel transceiver array coil (23) and local B1+ shimming at 7 T. Our goals were 1) to determine if artifact free spectra of similar quality to those reported in the occipital lobe (2,7) could be obtained from brain regions that are of interest for various neurological disorders, namely the frontal white matter (demyelinating white matter diseases), posterior cingulate (Alzheimer’s disease), putamen (Huntington’s and Parkinson’s diseases), substantia nigra (Parkinson’s disease), pons (spinocerebellar ataxias, motor neuron diseases) and cerebellar vermis (spinocerebellar ataxias), and 2) to quantify neurochemical profiles from these VOIs and to compare them to prior biochemical literature regarding neurochemical patterns in these regions.
Methods
Subjects
Fourteen healthy volunteers (8 females, 6 males, age (mean ± SD) = 32 ± 10) participated in this study after giving informed consent using procedures approved by the Institutional Review Board: Human Subjects Committee of the University of Minnesota.
MR Protocol
All measurements were performed on a 90-cm bore 7 T magnet (Magnex Scientific, Abingdon, UK) equipped with a head or body gradient coil (a maximum gradient amplitude of 40 mT/m and a slew rate of 170 mT/m/ms) and interfaced to a Siemens Syngo console (Siemens, Erlangen, Germany) with sixteen independent RF receivers. The body gradient coil included second-order shim coils with maximum shim strengths of Z2 = 6.2 mT/m2 and ZX, ZY, XY and X2-Y2 = 2.5 mT/m2 at a current of 20 A, while all second order shim coils in the head gradient system had a strength of 6.2 mT/m2 at a current of 20 A. A 16-channel transceiver array coil (23) was driven by sixteen 1 kW RF amplifiers (CPC, Brentwood, NY) which allowed independent control of phases and/or magnitudes of each transmit element of the array for B1+ shimming (24). 1 kW RF amplifiers were calibrated to deliver 900 W peak power, however only half of the transmitted power was actually available at the coil ports due to losses in cables and connectors. An in house built 16-channel monitoring system was used to continuously monitor the forward and reflected RF power on each channel which was averaged over two moving windows of 10 seconds and 10 minutes (12). If the power input into any coil element exceeded the predefined FDA threshold (3 / 16 Watts/kg/channel, conservatively assuming power deposition in only the head weighing ~ 4 kg), the scan was aborted. Besides the continuous RF power monitoring used during in vivo experiments, numeric electromagnetic simulations were also used to verify that global and local specific absorption rates (SAR) corresponding to our B1+ shimming approach were in compliance with U.S. Food and Drug Administration (FDA) guidelines. The 16-channel transceiver array coil loaded with a human head was modeled in the finite difference time domain (XFDTD, Remcom Inc, PA, USA). B1+ shimming solutions were performed within this model for VOIs defined in each of the anatomical target used in experiments, using the same B1+ phase shimming algorithm. For each corresponding B1+ shim solution the input power was scaled to match the experimentally measured B1+ value. Using the exact shape, amplitude and duration of each RF pulse used in the sequence for in vivo experiments, with same TR, SAR was then calculated over the head model. For each B1+ solution, global (over the whole head) and local (averaged over 1g of tissue) SAR values were always found smaller than 3 Watts/kg and 8 Watts/kg, respectively, within FDA guidelines (data not shown) (25).
Before the MRS acquisition from each VOI, local B1+ shimming was performed over a region of interest (ROI) that encompassed the VOI. Low flip angle gradient echo (GRE) images were acquired for B1+ shimming when pulsing the RF power through one coil at a time, while the receive signal was sampled on all 16 channels (field of view (FOV) = 168 × 256 mm2, repetition time (TR) = 60 ms, echo time (TE) = 3.6 ms, nominal flip angle (FA) = 15°, slice thickness 4 mm). The relative transmit B1+ phases were calculated using the B1+ phase formalism introduced by Van de Moortele et al (10). Local B1+ phase shimming was performed by averaging the phase of each channel over a ROI and then subtracting the normalized phase from the respective channel to minimize the destructive phase cancellation and maximize the fraction of available B1+. Note that the fraction of available B1+, which was defined as the ratio between the magnitude of the sum of the complex B1+ of each transmit channel and the sum of their magnitudes (14), can vary between 0 (when interferences are completely destructive) and 1 (when interferences are completely constructive). The predicted relative transmit efficiency (RTE) achievable with the local B1+ phase shimming technique relative to an initial transmit phase (set in 22.5 degree steps between adjacent elements) was calculated, based on the relative B1+ maps, from the postshim to preshim ratio of fraction of available B1+ averaged over the ROI (14). Note that only the phase, but not the magnitude, of each transmit channel was modulated relative to the others with our B1+ shimming algorithm.
Sagittal and transverse multislice images were acquired with a turbo spin echo sequence (FOV = 180 × 180 mm2, TR = 3 s, TE = 93 ms, FA = 150 °, slice thickness 3 mm, 48 slices, one average) for selection of the VOI. First- and second-order shims were adjusted using FASTMAP (fast, automatic shimming technique by mapping along projections) with echo-planar imaging (EPI) readout (26). Spectra were measured by a short-echo STEAM sequence (TR = 5 s, TE = 8 ms, mixing time (TM) = 32 ms). The STEAM sequence combined with 3-D OVS and VAPOR (variable-power RF pulses with optimized relaxation delays) water suppression previously developed using a half-volume coil (22) was utilized with the following modifications: The asymmetric RF pulses used for STEAM slice selection were replaced by symmetric sinc RF pulses with broader bandwidth (1.5 ms, 5.9 kHz bandwidth) requiring a peak power B1 of 34 µT (γB1/2π = 1.46 kHz). In the previous work, a higher RF power was used for the OVS slab in y-dimension further away from the coil plane than the slab near the coil to account for the decrease in B1+ field with distance from the half-volume coil, whereas the same power magnitudes were used for the OVS pulses (hyperbolic secant, 5.0 ms, 8.4 kHz bandwidth) in each dimension here. The VAPOR water suppression parameters were unchanged from before (22) while crusher gradients were further optimized to provide artifact free spectra from all VOI. After the local B1+ phase shimming procedure for each VOI, the RF power magnitude for the 90° STEAM pulses was calibrated by monitoring the signal intensity while increasing the RF power and choosing the RF power setting that produced the maximum signal. The power magnitudes of OVS and VAPOR RF pulses were automatically set relative to the 90° STEAM pulses. Excellent water suppression in all brain regions, using the RF power setting derived from the STEAM RF power calibration, confirmed that a 90° flip angle of STEAM pulses, requiring a B1+ field of 34 µT was always reached. Spectra were acquired from 7 VOIs: occipital cortex (20 × 20 × 20 mm3, number of transients (NT) = 128), posterior cingulate (20 × 20 × 20 mm3, NT = 128), frontal white matter (20 × 20 × 20 mm3, NT = 128), putamen (13 × 13 × 15 mm3, NT = 256), substantia nigra (6 × 13 × 13 mm3, NT = 512), pons (15 × 15 × 15 mm3, NT = 256) and cerebellar vermis (10 × 25 × 25 mm3, NT = 128), each from 5 healthy volunteers. The unsuppressed water signal acquired from the same VOI was used to remove residual eddy current effects and to reconstruct the phased array spectra (27). This included weighting the spectra based on the sensitivity of each receive element at the VOI and correcting for the different constant phase shift terms of the complex spectra prior to the summation. Single scan spectra summed from 16 channels were corrected for frequency and phase variations induced by subject motion and then summed. When insufficient SNR did not permit correction of single acquisitions (in the pons, putamen and substantia nigra) data were averaged over 4 (pons and putamen) or 32 (substantia nigra) transients, corrected for frequency shifts and summed.
Metabolite quantification
Metabolites were quantified using LCModel (28,29). The model spectra of alanine (Ala), aspartate (Asp), ascorbate/vitamin C (Asc), glycerophosphocholine (GPC), phosphocholine (PC), creatine (Cr), phosphocreatine (PCr), γ-amino-butyric acid (GABA), glucose (Glc), Gln, Glu, GSH, myo-Ins, lactate (Lac), NAA, N-acetylaspartylglutamate (NAAG), phosphoethanolamine (PE), scyllo-inositol (scyllo-Ins) and taurine (Tau) were generated based on previously reported chemical shifts and coupling constants (30,31). Macromolecule spectra were acquired from the occipital cortex of 5 volunteers using an inversion recovery sequence (TR = 2 s, inversion time = 0.680 s) (32). Metabolite concentrations were obtained relative to an unsuppressed water spectrum acquired from the same VOI assuming a water content of 72% for frontal white matter and pons, 78% for putamen, 76% for substantia nigra and 82% for occipital cortex, posterior cingulate and cerebellar vermis, which primarily contain gray matter (33–35). Concentrations were not corrected for T1 and T2 effects and cerebrospinal fluid contribution to the VOI. Metabolites quantified with CRLB (estimated error of the metabolite quantification) > 50% were classified as not detected. Only metabolites quantified with CRLB ≤ 50% in at least three of the five spectra from a brain region were included in the final neurochemical profile. If the correlation between two metabolites was consistently high (correlation coefficient < −0.5) in a given region, their sum was reported, e.g. total creatine (Cr+PCr), total choline (GPC+PC) and Glc+Tau.
Statistics
One-way analysis of variance (ANOVA) with Tukey post hoc test was used to compare the concentrations at each of the seven locations for each metabolite.
Results
B1+ optimization
ROIs larger than and concentric with the selected VOIs were chosen to optimize the phases of the B1+ fields transmitted from each of the 16 channels. Two typical ROIs defined for local B1+ shimming are shown on transverse anatomical images in Figure 1A (occipital cortex) and D (substantia nigra). The phases of channels 1 through 16 were set to 0 to 360° in increments of 22.5° before local B1+ shimming. Low flip angle GRE images were utilized to generate relative B1+ maps both before and after implementation of local B1+ shim phases to evaluate the predicted RTE within the ROI. For instance, in the occipital cortex, a region in the periphery of the brain, 34% of the available B1+ was realized before B1+ shimming (Fig. 1B). After B1+ shimming, 89% of the available B1+ was realized within the same ROI (Fig. 1C), corresponding to a predicted RTE of 2.64. On the other hand, in the substantia nigra, a more central region in the brain, the fractions of available B1+ before and after B1+ shimming were 73% and 84%, respectively, and the predicted RTE was 1.16. The averages of predicted RTE values are shown in Table 1 for all brain regions. These values were even higher when calculating the average B1+ after local B1+ shimming only within the VOI used for spectroscopy, since the maximum B1+ efficiency was obtained in the center of the ROI (Fig. 1). That a B1+ of at least 34 µT was available for all brain regions was confirmed directly by calibration of the RF pulses in STEAM.
Table 1.
Region of Interest | RTE (After / Before B1+ shimming) |
---|---|
Occipital cortex | 2.5 ± 0.2 |
Posterior cingulate | 1.4 ± 0.4 |
Frontal white matter | 1.9 ± 0.2 |
Putamen | 1.6 ± 0.2 |
Substantia nigra | 1.2 ± 0.1 |
Pons | 1.3 ± 0.1 |
Cerebellar vermis | 3.3 ± 0.3 |
Pulse sequence optimization
The modifications in the STEAM sequence relative to the one previously developed using a half-volume coil (22) provided optimum performance with the 16-channel transceiver array coil. First, the broader bandwidth symmetric sinc RF pulses used for slice selection resulted in slightly reduced chemical shift displacement error (< 5% /ppm/direction). Second, equal OVS power magnitudes in each dimension provided optimum suppression of signal from outside of the VOI because the B1+ field of the 16-channel coil after local B1+ shimming was almost symmetric around the VOI in every dimension. Third, the VAPOR water suppression parameters previously optimized for minimum sensitivity to T1 and B1+ variation (22) provided optimum water suppression with the 16-channel coil as well. Finally, crusher gradients used for STEAM, OVS and VAPOR adjusted to suppress unwanted stimulated echoes resulted in artifact-free spectra from all brain regions studied (Fig. 2).
Spectral quality
Figure 2 shows representative spectra obtained from different brain regions at 7 T. In all brain regions, the residual water signal was smaller than the major metabolite peaks. In addition, the double localization accomplished by STEAM and OVS eliminated signals from outside the VOI, such as lipid signals from the subcutaneous tissue, which resulted in artifact-free spectra with a flat baseline. This excellent quality was consistently achieved in all brain regions (Fig. 2). Localized B0 shimming using FASTMAP resulted in water linewidths (full width at half maximum (FWHM)) ranging from 11 Hz (in posterior cingulate) to 18 Hz (in substantia nigra) (Table 2).
Table 2.
Volume of Interest | FWHM (Hz) |
---|---|
Occipital cortex | 12.7 ± 0.3 |
Posterior cingulate | 11.3 ± 0.7 |
Frontal white matter | 15.7 ± 0.8 |
Putamen | 15.9 ± 1.2 |
Substantia nigra | 18.0 ± 1.0 |
Pons | 14.3 ± 1.9 |
Cerebellar vermis | 14.5 ± 0.6 |
Neurochemical profiles
The mean concentrations of metabolites that met our criteria for reliable quantification in at least six of the seven brain regions are shown in Figure 3A. Both the sum and individual values are reported for NAA and NAAG because these metabolites could be reliably distinguished (correlation coefficient between concentrations less negative than −0.5, Fig. 4) in all regions with CRLB < 10% except substantia nigra and putamen (correlation coefficient ~ −0.65, CRLB < 30%). Eight other metabolites (GABA, Glu, GSH, myo-Ins, scyllo-Ins, Cr+PCr, GPC+PC and Glc+Tau) were quantified with average CRLB ranging between 1–35% in all brain regions (Fig. 3B). Asc, Gln and Lac were quantified reliably in all brain regions (CRLB < 30%) except substantia nigra.
The comparison of metabolite concentrations revealed neurochemical profiles characteristic of different brain regions (Fig. 3A). For instance, the GABA level in the substantia nigra (2.5 ± 0.15 µmol/g) was 2–3 fold higher (p < 0.001) than the other brain regions (0.5 – 1.8 µmol/g). The cerebellar vermis had the highest total creatine (12.8 ± 0.8 µmol/g, p < 0.001) and Glc+Tau level (5.1 ± 0.1, µmol/g, p < 0.001). A high (GPC+PC)/(Cr+PCr) ratio was apparent from the pons spectrum (Fig. 2), which resulted primarily from higher total choline (2.9 ± 0.3 µmol/g) than other regions. Total NAA (NAA + NAAG) was fairly uniformly distributed between regions (11.6 – 13.6 µmol/g). The lowest Glu level was in the substantia nigra (5.9 ± 0.5 µmol/g) and the highest Glu levels were observed in the posterior cingulate and putamen (10.8 ± 0.5 and 10.7 ± 0.3 µmol/g, respectively). The highest myo-Ins levels were quantified in the pons and the cerebellar vermis (8.4 ± 0.7 and 9.1 ± 1.1 µmol/g, respectively). The GSH level varied from 0.50 ± 0.1 µmol/g (occipital cortex) to 1.2 ± 0.2 µmol/g (cerebellar vermis) and the scyllo-Ins varied from 0.2 ± 0.1 µmol/g (frontal white matter) to 0.5 ± 0.1 µmol/g (substantia nigra).
Discussion
This study demonstrated that high quality single-voxel short-echo STEAM spectra can be obtained from clinically relevant brain regions at 7 T using a transceiver array coil and local B1+ shimming. Importantly, our 7 T scanner is operated with a clinical console, demonstrating the feasibility of implementing the technology on clinical platforms. The spectral quality previously reported in the occipital cortex at 7 T using a half-volume RF coil (2,7) was reproduced with a 16-channel transceiver array coil (Fig. 2). In addition, spectra of high quality were acquired from other brain regions affected in various neurological disorders. Neurochemical profiles quantified from these spectra were consistent with biochemical literature (see below). To our knowledge, these extended profiles of region specific neurochemical concentrations are reported at 7 T for the first time.
Previously, single voxel, short-echo 1H MRS studies at 7 T utilized half-volume coils and therefore reported neurochemical profiles of only the occipital cortex in humans (2–7,22). Flexibility in selecting VOIs, especially deeper in the brain requires the use of volume head coils for both transmission and detection. This, however, creates challenges because the B1 distribution in the human head for a volume coil is extremely non-uniform (9,10,36,37). In the center of the brain, transmit and receive B1 associated with individual current carrying elements of the volume coil add approximately in phase resulting in highest possible B1 (10,36); however, B1 fields generated by the individual current carrying elements tend to cancel each other in the periphery and ventral regions of the brain due to destructive interferences. In this study, we utilized a transceiver array coil driven by a multichannel transmit system, which allowed local B1+ shimming to minimize the B1+ losses. Optimizing the transmit phases in the individual coil channels enabled to maximize the available B1+ magnitude in the selected VOIs (Fig. 1). The predicted RTE values ranged from 1.2 in the substantia nigra to 3.3 in the cerebellar vermis (Table 2). These results are in agreement with the fact that at UHF, constructive interferences yield increased magnitude of B1+ field in the center of the brain, whereas destructive interferences cause a reduction in magnitude of B1+ field in the periphery of the brain (10). Thus, in this study, VOIs selected in the periphery of the brain and especially in the cerebellum benefited more substantially from B1+ shimming than VOIs in the center of the brain.
The hardware available in this study (a 16-channel transceiver array coil driven by sixteen 1 kW RF amplifiers) and improved RTE by local B1+ shimming provided a transmit field of at least 34 µT in all studied brain regions, which was confirmed directly by calibration of the RF pulses in STEAM. The available peak B1+ field combined with high bandwidth RF pulses resulted in a reasonably low chemical shift displacement error (< 5% /ppm/direction). In general, if sufficiently high B1+ is not achievable, extending the duration of RF pulses in the MRS localization sequence is necessary. However, chemical shift displacement errors at UHF quickly become unacceptably large with increasing RF pulse length and decreasing bandwidths when conventional, amplitude modulated RF pulses are utilized. Another possibility for reducing the chemical shift displacement error when B1+ is low is to use broadband adiabatic RF pulses for slice selection (38,39). However, slice selective adiabatic excitation pulses are currently not available; therefore the localization must be achieved with multiple inversion pulses at the expense of much longer TE as in the LASER technique (38) or by forgoing single shot acquisition as in the ISIS method (40,41).
For this study, the STEAM sequence was chosen despite the loss of half of the available signal, primarily to minimize relaxation effects at an ultra-short echo time, but also to have a low chemical shift displacement artifact and to compare spectral quality and metabolite quantification to previously published work in the occipital cortex at 7 T (2–4,7,22). Transverse relaxation at long TE results in substantial signal loss at higher fields since the Hahn T2 of metabolites decreases with increasing field strength due to an increased dynamic dephasing contribution (11,12). For instance, the T2 of NAA decreases from 240 ms at 4 T to 160 ms at 7 T (11). Thus, even a modest increase of TE from 8 to 30 ms would lead to a 12% lower NAA signal at 7 T. In addition, J-evolution was minimized at the ultra-short TE, which facilitated the quantification of metabolites with coupled spin systems.
To achieve high spectral resolution at 7 T, efficient B0 shimming is very important. In this study, the strength of the second-order shim system combined with efficient B0 shimming (FASTMAP) resulted in highly reproducible linewidths in the selected VOIs. This was shown by less than 15% standard deviation of the water signal linewidth in all brain regions (Table 2). Considering an increase in linewidth at 7 T by a factor of 1.5 relative to 4 T (2), the linewidths obtained in the substantia nigra were in agreement with published results for substantia nigra at 4 T (21). Similarly, the previously reported linewidths for the occipital cortex at 7 T (2) were reproduced in the current study. Linewidths obtained in the substantia nigra, putamen and frontal white matter were substantially higher than those in the other VOIs due to the effects of high iron content in the substantia nigra and putamen (42) and global magnetic field inhomogeneity in frontal white matter due to the close proximity of the nasal air cavities.
The achieved spectral quality (high spectral resolution, SNR, excellent localization performance, efficient water suppression, and a distortionless baseline) allowed reliable quantification of 17 metabolites in occipital cortex (VOI = 8 mL) using LCModel analysis. Concentrations of metabolites quantified in this study were in good agreement with recently reported values acquired from the same brain location using a very similar approach except for the RF coil (2). The average difference between concentrations obtained in the current study and the prior report was only 0.25 µmol/g.
Nine metabolites were reliably estimated using LCModel analysis in all studied brain regions. In addition, nine metabolites were quantified with average CRLB less than 20% in 5 of the 7 brain regions studied (Fig. 3B), indicating that these were the most robustly quantified neurochemicals. In general, changes in neurochemical levels greater than twice the CRLB can be detected in individual spectra with 95% confidence (43). Hence, disease related alterations in those metabolites quantified with CRLB above 20% can only be detected if the effect sizes are quite large (more than twice the CRLB).
Comparison of metabolite concentrations between different brain regions revealed significant regional variations (Fig. 3). The findings were in excellent agreement with prior neurochemical and MRS studies of anatomical locations most similar to those presented here. For example, the high cerebellar total creatine level was in agreement with previous reports (20,44–46). In addition, the highest Glc+Tau concentration obtained in cerebellar vermis was consistent with high cerebellar Tau (47) and Glc (48) levels reported relative to other brain regions. Confirming previous MRS studies (44,49), the highest total choline levels were observed in the pons and the lowest total choline levels were measured in the occipital cortex. The concentration of total NAA had a fairly homogenous distribution, consistent with previous MRS studies (44,49). The GABA level was significantly higher in the substantia nigra than other regions, also in agreement with both MRS (21) and neurochemistry literature (47). High myo-Ins concentrations in the pons and vermis were also consistent with prior MRS literature (46).
In conclusion, the combination of a multichannel transceiver array coil and local B1+ shimming enabled us to acquire excellent single voxel, short-echo STEAM spectra from multiple brain regions at 7 T. The high spectral quality facilitated the quantification of neurochemical profiles consisting of at least nine metabolites including GABA, Glu and GSH. These findings demonstrate that single voxel 1H MRS at 7 T can reliably detect region-specific neurochemical patterns in the human brain and has the potential of becoming an objective tool to monitor neurochemical profile alterations associated with several neurological diseases.
Acknowledgements
We thank the staff of the Center for MR Research for maintaining and supporting the MR system, in particular Dr. Gregor Adriany for assistance with the 16-channel coil and the 7 T scanner. We would like to thank Can Akgun for his invaluable assistance with the SAR simulations. This work was supported by the Dana Foundation (G.Ö.) and National Institute on Aging research grant R21 AG029582 (M.T.). The Center for MR Research is supported by the National Center for Research Resources (NCRR) biotechnology research resource grant P41 RR008079, the Neuroscience Center Core Blueprint Award P30 NS057091 and Keck Foundation. Coil support was provided by the National Institute of Biomedical Imaging and Bioengineering grant R01 EB006835 (J. Thomas Vaughan).
Abbreviations Used
- Ala
alanine
- Asc
ascorbate
- Asp
aspartate
- Cr
creatine
- CRLB
Cramér-Rao lower bounds
- FA
flip angle
- FOV
field of view
- FWHM
full width at half maximum
- GABA
γ-aminobutyric acid
- Glc
glucose
- Gln
glutamine
- GPC
glycerophosphocholine
- GRE
gradient echo
- GSH
glutathione
- Glu
glutamate
- Lac
lactate
- MRSI
magnetic resonance spectroscopic imaging
- myo-Ins
myo-inositol
- NAA
N-acetylaspartate
- NAAG
N-acetylaspartylglutamate
- NT
number of transients
- OVS
outer volume suppression
- PC
phosphocholine
- PCr
phosphocreatine
- PE
phosphoethanolamine
- ROI
region of interest
- RTE
relative transmit efficiency
- SAR
specific absorption rate
- scyllo-Ins
scyllo-inositol
- SNR
signal-to-noise ratio
- Tau
taurine; TE, echo time
- TE
echo time
- TM
mixing time
- TR
repetition time
- UHF
ultra high field
- VAPOR
variable-power RF pulses with optimized relaxation delays
- VOI
volume of interest
References
- 1.Uğurbil K, Adriany G, Andersen P, Chen W, Garwood M, Gruetter R, Henry PG, Kim SG, Lieu H, Tkáč I, Vaughan T, Van De Moortele PF, Yacoub E, Zhu XH. Ultrahigh field magnetic resonance imaging and spectroscopy. Magn Reson Imaging. 2003;21(10):1263–1281. doi: 10.1016/j.mri.2003.08.027. [DOI] [PubMed] [Google Scholar]
- 2.Tkáč I, Öz G, Adriany G, Uğurbil K, Gruetter R. In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: metabolite quantification at 4T vs. 7T. Magn Reson Med. 2009;62(4):868–879. doi: 10.1002/mrm.22086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Mangia S, Tkáč I, Gruetter R, Van De Moortele PF, Giove F, Maraviglia B, Uğurbil K. Sensitivity of single-voxel 1H-MRS in investigating the metabolism of the activated human visual cortex at 7 T. Magn Reson Imaging. 2006;24(4):343–348. doi: 10.1016/j.mri.2005.12.023. [DOI] [PubMed] [Google Scholar]
- 4.Terpstra M, Uğurbil K, Tkáč I. Noninvasive quantification of human brain ascorbate concentration using 1H NMR spectroscopy at 7 T. NMR Biomed. 2010;23(3):227–232. doi: 10.1002/nbm.1423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Mekle R, Mlynárik V, Gambarota G, Hergt M, Krueger G, Gruetter R. MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T. Magn Reson Med. 2009;61(6):1279–1285. doi: 10.1002/mrm.21961. [DOI] [PubMed] [Google Scholar]
- 6.Gambarota G, Mekle R, Xin L, Hergt M, van der Zwaag W, Krueger G, Gruetter R. In vivo measurement of glycine with short echo-time 1H MRS in human brain at 7 T. MAGMA. 2009;22(1):1–4. doi: 10.1007/s10334-008-0152-0. [DOI] [PubMed] [Google Scholar]
- 7.Tkáč I, Andersen P, Adriany G, Merkle H, Uğurbil K, Gruetter R. In vivo 1H NMR spectroscopy of the human brain at 7 T. Magn Reson Med. 2001;46(3):451–456. doi: 10.1002/mrm.1213. [DOI] [PubMed] [Google Scholar]
- 8.Scheenen TW, Heerschap A, Klomp DW. Towards 1H-MRSI of the human brain at 7T with slice-selective adiabatic refocusing pulses. MAGMA. 2008;21(1–2):95–101. doi: 10.1007/s10334-007-0094-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Vaughan JT, Garwood M, Collins CM, Liu W, DelaBarre L, Adriany G, Andersen P, Merkle H, Goebel R, Smith MB, Uğurbil K. 7T vs. 4T: RF power, homogeneity, and signal-to-noise comparison in head images. Magn Reson Med. 2001;46(1):24–30. doi: 10.1002/mrm.1156. [DOI] [PubMed] [Google Scholar]
- 10.Van de Moortele PF, Akgün C, Adriany G, Moeller S, Ritter J, Collins CM, Smith MB, Vaughan JT, Uğurbil K. B1 destructive interferences and spatial phase patterns at 7 T with a head transceiver array coil. Magn Reson Med. 2005;54(6):1503–1518. doi: 10.1002/mrm.20708. [DOI] [PubMed] [Google Scholar]
- 11.Michaeli S, Garwood M, Zhu XH, DelaBarre L, Andersen P, Adriany G, Merkle H, Uğurbil K, Chen W. Proton T2 relaxation study of water, N-acetylaspartate, and creatine in human brain using Hahn and Carr-Purcell spin echoes at 4T and 7T. Magn Reson Med. 2002;47(4):629–633. doi: 10.1002/mrm.10135. [DOI] [PubMed] [Google Scholar]
- 12.Deelchand DK, Van de Moortele PF, Adriany G, Iltis I, Andersen P, Strupp JP, Vaughan JT, Ugurbil K, Henry PG. In vivo 1H NMR spectroscopy of the human brain at 9.4 T: initial results. J Magn Reson. 2010;206(1):74–80. doi: 10.1016/j.jmr.2010.06.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Henning A, Fuchs A, Murdoch JB, Boesiger P. Slice-selective FID acquisition, localized by outer volume suppression (FIDLOVS) for 1H-MRSI of the human brain at 7 T with minimal signal loss. NMR Biomed. 2009;22(7):683–696. doi: 10.1002/nbm.1366. [DOI] [PubMed] [Google Scholar]
- 14.Metzger GJ, Snyder C, Akgün C, Vaughan T, Uğurbil K, Van de Moortele PF. Local B1+ shimming for prostate imaging with transceiver arrays at 7T based on subject-dependent transmit phase measurements. Magn Reson Med. 2008;59(2):396–409. doi: 10.1002/mrm.21476. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Van de Moortele PF, Snyder C, DelaBarre L, Akgün C, Wu X, Vaughan JT, Uğurbil K. Biomedical Magnetic Resonance Imaging and Spectroscopy at Very High Fields. Würzburg: 2006. Fast mapping of relative B1 phase in the human head at 9.4 Tesla with a 14 channel transceive coil array. [Google Scholar]
- 16.Hetherington HP, Avdievich NI, Kuznetsov AM, Pan JW. RF shimming for spectroscopic localization in the human brain at 7 T. Magn Reson Med. 2010;63(1):9–19. doi: 10.1002/mrm.22182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Avdievich NI, Pan JW, Baehring JM, Spencer DD, Hetherington HP. Short echo spectroscopic imaging of the human brain at 7T using transceiver arrays. Magn Reson Med. 2009;62(1):17–25. doi: 10.1002/mrm.21970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Mao W, Smith MB, Collins CM. Exploring the limits of RF shimming for high-field MRI of the human head. Magn Reson Med. 2006;56(4):918–922. doi: 10.1002/mrm.21013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Öz G, Tkáč I, Charnas LR, Choi IY, Bjoraker KJ, Shapiro EG, Gruetter R. Assessment of adrenoleukodystrophy lesions by high field MRS in non-sedated pediatric patients. Neurology. 2005;64(3):434–441. doi: 10.1212/01.WNL.0000150906.52208.E7. [DOI] [PubMed] [Google Scholar]
- 20.Öz G, Hutter D, Tkáč I, Clark HB, Gross MD, Jiang H, Eberly LE, Bushara KO, Gomez CM. Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status. Mov Disord. 2010 doi: 10.1002/mds.23067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Öz G, Terpstra M, Tkáč I, Aia P, Lowary J, Tuite PJ, Gruetter R. Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations. Magn Reson Med. 2006;55(2):296–301. doi: 10.1002/mrm.20761. [DOI] [PubMed] [Google Scholar]
- 22.Tkáč I, Gruetter R. Methodology of 1H NMR Spectroscopy of the Human Brain at Very High Magnetic Fields. Appl Magn Reson. 2005;29(1):139–157. doi: 10.1007/BF03166960. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Adriany G, Van de Moortele PF, Ritter J, Moeller S, Auerbach EJ, Akgün C, Snyder CJ, Vaughan T, Uğurbil K. A geometrically adjustable 16-channel transmit/receive transmission line array for improved RF efficiency and parallel imaging performance at 7 Tesla. Magn Reson Med. 2008;59(3):590–597. doi: 10.1002/mrm.21488. [DOI] [PubMed] [Google Scholar]
- 24.Vaughan JT, Snyder CJ, DelaBarre LJ, Bolan PJ, Tian J, Bolinger L, Adriany G, Andersen P, Strupp J, Uğurbil K. Whole-body imaging at 7T: preliminary results. Magn Reson Med. 2009;61(1):244–248. doi: 10.1002/mrm.21751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.U.S. Department of Health and Human Services Food and Drug Administration; 2010. Dec 17, Guidance for Industry and FDA Staff: Criteria for Significant Risk Investigations of Magnetic Resonance Diagnostic Devices. http://wwwfdagov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm072686htm. [Google Scholar]
- 26.Gruetter R, Tkáč I. Field mapping without reference scan using asymmetric echo-planar techniques. Magn Reson Med. 2000;43(2):319–323. doi: 10.1002/(sici)1522-2594(200002)43:2<319::aid-mrm22>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
- 27.Natt O, Bezkorovaynyy V, Michaelis T, Frahm J. Use of phased array coils for a determination of absolute metabolite concentrations. Magn Reson Med. 2005;53(1):3–8. doi: 10.1002/mrm.20337. [DOI] [PubMed] [Google Scholar]
- 28.Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30(6):672–679. doi: 10.1002/mrm.1910300604. [DOI] [PubMed] [Google Scholar]
- 29.Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 2001;14(4):260–264. doi: 10.1002/nbm.698. [DOI] [PubMed] [Google Scholar]
- 30.Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 2000;13(3):129–153. doi: 10.1002/1099-1492(200005)13:3<129::aid-nbm619>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
- 31.Tkáč I. Refinement of simulated basis set for LCModel analysis. Proceedings 16th Scientific Meeting, International Society for Magnetic Resonance in Medicine; Toronto. 2008. p. 1624. [Google Scholar]
- 32.Behar KL, Rothman DL, Spencer DD, Petroff OA. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn Reson Med. 1994;32(3):294–302. doi: 10.1002/mrm.1910320304. [DOI] [PubMed] [Google Scholar]
- 33.Randall LO. Chemical topography of the brain. J Biol Chem. 1938;124:481–488. [Google Scholar]
- 34.Gelman N, Ewing JR, Gorell JM, Spickler EM, Solomon EG. Interregional variation of longitudinal relaxation rates in human brain at 3.0 T: relation to estimated iron and water contents. Magn Reson Med. 2001;45(1):71–79. doi: 10.1002/1522-2594(200101)45:1<71::aid-mrm1011>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
- 35.Siegel GJ, editor. Basic neurochemistry: molecular, cellular and medical aspects. Philadelphia: Lippincott-Raven Publishers; 1999. [Google Scholar]
- 36.Collins CM, Liu W, Schreiber W, Yang QX, Smith MB. Central brightening due to constructive interference with, without, and despite dielectric resonance. J Magn Reson Imaging. 2005;21(2):192–196. doi: 10.1002/jmri.20245. [DOI] [PubMed] [Google Scholar]
- 37.Yang QX, Wang J, Zhang X, Collins CM, Smith MB, Liu H, Zhu XH, Vaughan JT, Uğurbil K, Chen W. Analysis of wave behavior in lossy dielectric samples at high field. Magn Reson Med. 2002;47(5):982–989. doi: 10.1002/mrm.10137. [DOI] [PubMed] [Google Scholar]
- 38.Garwood M, DelaBarre L. The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. J Magn Reson. 2001;153(2):155–177. doi: 10.1006/jmre.2001.2340. [DOI] [PubMed] [Google Scholar]
- 39.Tannus A, Garwood M. Adiabatic pulses. NMR Biomed. 1997;10(8):423–434. doi: 10.1002/(sici)1099-1492(199712)10:8<423::aid-nbm488>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
- 40.Ordidge RJ, Connelly A, Lohman JAB. Image-selected in Vivo spectroscopy (ISIS). A new technique for spatially selective nmr spectroscopy. Journal of Magnetic Resonance. 1986;66(2):283–294. [Google Scholar]
- 41.Mlynárik V, Gambarota G, Frenkel H, Gruetter R. Localized short-echo-time proton MR spectroscopy with full signal-intensity acquisition. Magn Reson Med. 2006;56(5):965–970. doi: 10.1002/mrm.21043. [DOI] [PubMed] [Google Scholar]
- 42.Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MB. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem. 1989;52(2):515–520. doi: 10.1111/j.1471-4159.1989.tb09150.x. [DOI] [PubMed] [Google Scholar]
- 43.Provencher SW. LCModel & LCMgui User’s Manual. 2001 [Google Scholar]
- 44.Baker EH, Basso G, Barker PB, Smith MA, Bonekamp D, Horska A. Regional apparent metabolite concentrations in young adult brain measured by 1H MR spectroscopy at 3 Tesla. J Magn Reson Imaging. 2008;27(3):489–499. doi: 10.1002/jmri.21285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Pouwels PJ, Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med. 1998;39(1):53–60. doi: 10.1002/mrm.1910390110. [DOI] [PubMed] [Google Scholar]
- 46.Viau M, Marchand L, Bard C, Boulanger Y. 1H magnetic resonance spectroscopy of autosomal ataxias. Brain Res. 2005;1049(2):191–202. doi: 10.1016/j.brainres.2005.05.015. [DOI] [PubMed] [Google Scholar]
- 47.Perry TL. Cerebral amino acid pools. In: Lajtha A, editor. Handbook of Neurochemistry. 2nd ed. Volume 1. New York: Plenum Press; 1982. pp. 151–180. [Google Scholar]
- 48.Swanson RA, Sagar SM, Sharp FR. Regional brain glycogen stores and metabolism during complete global ischaemia. Neurol Res. 1989;11(1):24–28. doi: 10.1080/01616412.1989.11739856. [DOI] [PubMed] [Google Scholar]
- 49.Jacobs MA, Horska A, van Zijl PC, Barker PB. Quantitative proton MR spectroscopic imaging of normal human cerebellum and brain stem. Magn Reson Med. 2001;46(4):699–705. doi: 10.1002/mrm.1248. [DOI] [PubMed] [Google Scholar]